1-2 of 2
Wolfram Klapper, MD PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Alternating Courses of 3x CHOP and 3x DHAP Plus Rituximab Followed by a High Dose ARA-C Containing Myeloablative Regimen and Autologous Stem Cell Transplantation (ASCT) Increases Overall Survival When Compared to 6 Courses of CHOP Plus Rituximab Followed by Myeloablative Radiochemotherapy and ASCT in Mantle Cell Lymphoma: Final Analysis of the MCL Younger Trial of the European Mantle Cell Lymphoma Network ( MCL net )

Olivier Hermine, MD, PhD, Eva Hoster, Jan Walewski, Vincent Ribrag, MD, Nicole Brousse, M.D., Catherine Thieblemont, MD, PhD, Reda Bouabdallah, MD, Hartmut Dohner, MD, Pierre Feugier, MD, PhD, Roswitha Forspointner, MD, Corinne Haioun, MD, Michael Kneba, MD, PhD, Mathias Hänel, MD, Olivier Casasnovas, MD, Roland H. Mertelsmann, MD, PhD, Michael Hallek, MD, Andre Bosly, MD, PhD, M Nowacki, MD, Wolfram Klapper, MD PhD, Christian Gisselbrecht, MD, Bertrand Coiffier, MD, PhD, Michael Unterhalt, Wolfgang Hiddemann, MD, Martin H. Dreyling, MD
Journal: Blood
Blood (2012) 120 (21): 151.
https://doi.org/10.1182/blood.V120.21.151.151
Published: 2012
Journal Articles

Non-Hodgkin Lymphoma in Adolescents: Experiences in 378 Adolescent NHL Patients Treated According to Pediatric NHL-BFM Protocols.

Birgit Burkhardt, MD, PhD, Ilske Oschlies, MD, Wolfram Klapper, MD, PhD, Martin Zimmermann, PhD, Andrea Meinhardt, MD, Eva Landmann, MD, Wilhelm Woessmann, MD, PhD, Georg Mann, MD, Felix Niggli, MD, Martin Schrappe, MD, PhD, Alfred Reiter, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 102.
https://doi.org/10.1182/blood.V114.22.102.102
Published: 2009